Explore › Finding
Finding null
In patients with NAFLD and diabetes, insulin use alone was not significantly associated with the risk of hepatocellular carcinoma compared with no diabetes medication.
Effect sizeHR 1.05
CI95% CI 0.88-1.27
Comparatorno diabetes medication
Effect summarynull; HR 1.05; CI: 95% CI 0.88-1.27

Connected entities

Interventions
insulin monotherapy
Conditions
Metastatic hepatocellular carcinoma
Outcomes
Hepatocellular carcinoma
Populations
Type 2 Diabetes Patients

Source

PMC9107529
Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease
Read on PMC → · View in graph →